Tech in Africa
RxAll wins USAID grant for a portable RxScanner platform for detecting chemical compounds in products that use artificial intelligence to determine their authenticity.
Low-quality counterfeit products threaten consumer safety while hindering economic growth in developing countries. Over 10 percent of medicines in developing countries are low quality and result in $21 billion worth of annual damages. RxAll developed RxScanner to accurately detect low-quality substances, handheld spectrometers detecting the number of chemical compounds present in substances or products such as medicines, and relies on proprietary artificial intelligence connecting to a central database that identifies compounds while sending reports to users.
A RxScanner is small enough to be used at the point of sales such as pharmacies and costs less than traditional laboratory tests. This device produces results in real-time and is easy to use in remote, low-resource settings from people with limited technological skills.
